Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

Twist Bioscience Corporation

TWSTNASDAQEQUITYCurrent

Quarterly Report

Filed Feb 3, 2025Accepted Feb 3, 2025, 4:09 PM ESTCIK 1581280Accession 0001628280-25-003461
Share

Company context

At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets. We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal - more experiments, more iterations, more chances for remarkable discoveries.

Current securities

Recent company filings

  1. 144 filingSep 21, 2026
  2. 144 filingSep 21, 2026
  3. 144 filingSep 21, 2026
  4. 4 filingSep 21, 2026
  5. 144 filingSep 17, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗